NCT04733833 2023-02-01
A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19
Vascular Biogenics Ltd. operating as VBL Therapeutics
Phase 2 Completed
Vascular Biogenics Ltd. operating as VBL Therapeutics
Centre Leon Berard
Applied Biology, Inc.